Anna R Damato

7PUBLICATIONS
19CO-AUTHORS
Regenerative medicine (incl. stem cells)Predictive and prognostic markersGene and molecular therapyCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 07, 2025
A synthetic chronogenetic gene circuit for programmed circadian drug delivery.

Lara Pferdehirt, Anna R Damato, Kristin L Lenz

|May 20, 2024
Daily glucocorticoids promote glioblastoma growth and circadian synchrony to the host.

Maria F Gonzalez-Aponte, Anna R Damato, Tatiana Simon

|Jan 26, 2024
Circadian regulation of MGMT expression and promoter methylation underlies daily rhythms in TMZ sensitivity in glioblastoma.

Maria F Gonzalez-Aponte, Anna R Damato, Laura Lucía Trebucq

|Sep 25, 2023
Circadian regulation of MGMT expression and promoter methylation underlies daily rhythms in TMZ sensitivity in glioblastoma.

Maria F Gonzalez-Aponte, Anna R Damato, Laura Lucía Trebucq

|May 25, 2022
Synthetic gene circuits for preventing disruption of the circadian clock due to interleukin-1-induced inflammation.

Lara Pferdehirt, Anna R Damato, Michal Dudek

|May 23, 2022
A randomized feasibility study evaluating temozolomide circadian medicine in patients with glioma.

Anna R Damato, Ruth G N Katumba, Jingqin Luo

Pageof 2

Frequent Collaborators

7 joint publications

Erik D Herzog

4 joint publications

Maria F Gonzalez-Aponte

3 joint publications

Joshua B Rubin

3 joint publications

Tatiana Simon